DaCapo Brainscience

Cambridge, United States

DaCapo Brainscience develops disease-modifying therapies for neurodegenerative diseases, focusing on innovative treatments.

$20.0M raised

Jun 2025

Seed

Biotechnology Neuroscience

Top Investors

DNS Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DaCapo Brainscience

How much funding has DaCapo Brainscience raised?

DaCapo Brainscience has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.

Who are DaCapo Brainscience's investors?

DaCapo Brainscience's investors include DNS Capital.

Where is DaCapo Brainscience headquartered?

DaCapo Brainscience is headquartered in Cambridge, United States.

What does DaCapo Brainscience do?

DaCapo Brainscience develops disease-modifying therapies for neurodegenerative diseases, focusing on innovative treatments.

What stage is DaCapo Brainscience at?

DaCapo Brainscience is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 30, 2025.

MLA

"DaCapo Brainscience — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/dacapo-brainscience. Accessed July 2, 2026.

APA

VCBacked. (2025). DaCapo Brainscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/dacapo-brainscience

Wikipedia (cite web)

{{cite web |title=DaCapo Brainscience — Funding & Investors |url=https://www.vcbacked.co/company/dacapo-brainscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 30, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K